Institutional investors purchased a net $4.5 million shares of MNKD during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 19.79% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
D. E. SHAW & CO. LP Bought 4.1 Million shares of MannKind Corp
MILLENNIUM MANAGEMENT LLC Bought 2.1 Million shares of MannKind Corp
GSA CAPITAL PARTNERS LLP Bought 1.8 Million shares of MannKind Corp